Member Login

Please login to the WANADA website using the below form. If you have any issues logging in please email [email protected] or contact us on (08) 6557 9400.

Request Access

If you're a WANADA member and need access to the Hub, you can request access direct from WANADA.

Forgot your password?

Accessibility Options

WANADA is committed to access and inclusion. We are always working to improve the quality and accessibility of our website.

WANADA’s website is designed to be accessible for people with disability. We strive to meet the World Wide Web Consortium’s Web Content Accessibility Guidelines (WCAG) 2.0 at level AA.

If you have any difficulties using this site please contact us via [email protected] or via (08) 6557 9400

Accessibility options that may help you to access the site include:

Text size
Contrast
Accessibility Enquiries

E [email protected]

P (08) 6557 9400

Contact Us

General Enquiries

E [email protected]

P (08) 6557 9400

Address

WANADA
Whadjuk Noongar Country
Level 1, 1 Nash St
Perth WA 6000

Postal Address

WANADA
PO Box 8048
Perth, WA 6849

Social Media

Naloxone in Prison – Joint Media Release

Naloxone in Prison - Joint Media Statement

A coalition of health practitioners, harm reduction advocates and experts across the Nation are calling for expanded access to naloxone in prisons to protect against fatal overdoses from nitazenes and other synthetic opioids. In order to prevent avoidable deaths, the group is calling on each state and territory government to immediately:

  • Provide training to custodial officers to recognise overdose and administer naloxone
  • Ensure naloxone is accessible to custodial officers to promptly and effectively respond to overdose
  • Ensure that naloxone and naloxone training is routinely offered to all people exiting prison

Please read the media statement published by the Australian and Other Drugs Council (AADC).

Signatories to the media statement include:

Mary Harrod, CEO, NSW Users and Aids Association (NUAA)

Geoff Davey, CEO, QuIHN

Professor Alison Ritter AO, Director, Drug Policy Modelling Program (DPMP), UNSW

Liz Barrett, Chair, Harm Reduction in Prisons Working Group

Melanie Walker, CEO, Australian Alcohol and Other Drugs Council (AADC)

Dr Lise Lafferty, Senior Research Fellow, Centre for Social Research in Health (CSRH), UNSW

Sione Crawford, CEO, Harm Reduction Victoria

Professor Kate Dolan, Harm Reduction Australia, UNSW

John Didlick, Policy Analyst, Hepatitis Australia

Paul Dessauer, CEO, Peer Based Harm Reduction WA

Brent Bell, CEO, Hepatitis WA

Steven Drew, CEO, Hepatitis NSW

Ele Morrison, Deputy CEO, Australian Injecting and Illicit Drug Users League (AIVL)